Charles River Laboratories International (CRL) has been under a strong bear grip, hence the stock is down -1.39% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 1.07% in the past 1 week. The stock has risen by 1.58% in the past week indicating that the buyers are active at lower levels, but the stock is down -1.52% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 1.18% and the 50-Day Moving Average is 0.2%.The 200 Day SMA reached 6.1%. Charles River Laboratories International, Inc. has dropped 1.97% during the last 3-month period . Year-to-Date the stock performance stands at 5.01%.
Charles River Laboratories International (NYSE:CRL): After opening at $83.97, the stock dipped to an intraday low of $83.62 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $84.7 and the buying power remained strong till the end. The stock closed at $84.42 for the day, a gain of 0.98% for the day session. The total traded volume was 315,441. The stocks close on the previous trading day was $83.6.
Charles River Laboratories International, Inc. is a full service, early stage contract research company. The Company offers research models for the research and development of new drugs, devices and therapies. It develops a portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP that support the clients from target identification through preclinical development. The Company operates through three segments: Research Models and Services (RMS), which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides services that enables the clients to outsource their drug discovery research, critical, regulatory-required safety assessment testing and related drug discovery and development activities, and Manufacturing Support (Manufacturing), which is involved in the production and release of products manufactured by the clients.